| 000 | 01878 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250515204552.0 | ||
| 264 | 0 | _c20110916 | |
| 008 | 201109s 0 0 eng d | ||
| 022 | _a1573-0646 | ||
| 024 | 7 |
_a10.1007/s10637-010-9389-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTorres, Mylin A | |
| 245 | 0 | 0 |
_aAC480, formerly BMS-599626, a pan Her inhibitor, enhances radiosensitivity and radioresponse of head and neck squamous cell carcinoma cells in vitro and in vivo. _h[electronic resource] |
| 260 |
_bInvestigational new drugs _cAug 2011 |
||
| 300 |
_a554-61 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 |
_aCarbamates _xpharmacology |
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xdrug therapy |
| 650 | 0 | 4 | _aCell Count |
| 650 | 0 | 4 |
_aCell Cycle _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aErbB Receptors _xmetabolism |
| 650 | 0 | 4 |
_aHead and Neck Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aHistones _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunoprecipitation |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Nude |
| 650 | 0 | 4 |
_aRadiation Tolerance _xdrug effects |
| 650 | 0 | 4 | _aRadiation, Ionizing |
| 650 | 0 | 4 |
_aReceptor, ErbB-2 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aTriazines _xpharmacology |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _aRaju, Uma | |
| 700 | 1 | _aMolkentine, David | |
| 700 | 1 | _aRiesterer, Oliver | |
| 700 | 1 | _aMilas, Luka | |
| 700 | 1 | _aAng, K Kian | |
| 773 | 0 |
_tInvestigational new drugs _gvol. 29 _gno. 4 _gp. 554-61 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10637-010-9389-3 _zAvailable from publisher's website |
| 999 |
_c19492257 _d19492257 |
||